Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi and Simponi Aria
29.11.2023 - The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi (golimumab) in healthy adult subjects, met its primary endpointREYKJAVIK, Iceland, Nov. 29, 2023 (GLOBE NEWSWIRE) - Alvotech (NASDAQ: ALVO), a global ... Seite 1